This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Guardant Health, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Mohammad Reza Mokhtari
Introduction
Mohammad Reza Mokhtari is an accomplished inventor based in San Lorenzo, CA (US). He has made significant contributions to the field of genetic research, particularly in the detection of genetic variants. His innovative work has led to the development of methods that enhance the identification of nucleic acid variants.
Latest Patents
Mokhtari holds 1 patent for his invention titled "Genetic variant detection based on merged and unmerged reads." This patent describes methods and systems for improving the identification of nucleic acid variants. The invention focuses on identifying genetic sequence reads that share identical molecular barcodes and sequences among reads from a nucleic acid sequencer. It involves grouping these genetic reads into families and processing families that include split reads to detect variants in a sample of polynucleotide molecules.
Career Highlights
Mokhtari is currently employed at Guardant Health, Inc., a company known for its advancements in precision oncology. His work at Guardant Health has positioned him at the forefront of genetic research and innovation. His expertise in genetic variant detection has contributed to the company's mission of transforming cancer care.
Collaborations
Mokhtari has collaborated with notable colleagues, including Darya Chudova and Bahram Ghaffarzadeh Kermani. These collaborations have fostered a productive environment for innovation and research in the field of genetics.
Conclusion
Mohammad Reza Mokhtari's contributions to genetic research through his innovative patent and work at Guardant Health, Inc. highlight his role as a leading inventor in the field. His dedication to improving genetic variant detection continues to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
